During the past decade, UCLA Headache Research and Treatment Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Headache Research and Treatment Program" #1 collaborator was "University of California, Los Angeles" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Headache Research and Treatment Program" are "Headache" (1 trials), "Migraine" (1 trials) and "Migraine in Adolescents" (1 trials). Many other conditions were trialed in "UCLA Headache Research and Treatment Program" in a lesser frequency.

Most popular intervention types in "UCLA Headache Research and Treatment Program" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Melatonin" (2 trials), "Placebo" (1 trials), "Placebo oral capsule" (1 trials) and "eNeura SpringTMS" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Headache Research and Treatment Program" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Headache Research and Treatment Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UCLA Headache Research and Treatment Program, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Headache Research and Treatment Program, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".